BackOpiant Pharmaceuticals Overview

Opiant Pharmaceuticals Current Assets

Track Opiant Pharmaceuticals's current assets ($39M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$38.55M
↓ 43.21% YoYΔ $-29.33M vs prior year quarter

Peer trimmed avg / median

Loading

Opiant Pharmaceuticals Current Assets History

Loading

Opiant Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Opiant Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Opiant Pharmaceuticals (OPNT) FAQ

Opiant Pharmaceuticals (OPNT) currently reports a current assets of $39M as of September 2022. That compares with $68M in the prior-year period — down 43.2% year over year. Use the charts on this page to explore Opiant Pharmaceuticals's current assets history and peer comparisons.

Opiant Pharmaceuticals's current assets decreased from $68M to $39M — a 43.2% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Opiant Pharmaceuticals reported $39M in current assets as of September 2022. That compares with $68M in the prior-year period — down 43.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $39M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Opiant Pharmaceuticals, and consider following OPNT for alerts when major investors trade the stock.

Opiant Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $39M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPNT with unrelated industries.